Gentherm Sets September 10 Vote on Modine Performance Technologies Merger
THRM sits 53% above its 52-week low of $27.
Summary
Gentherm shareholders will vote September 10 on issuing ~20.8M shares (worth ~$882M) to acquire Modine's Performance Technologies business in a Reverse Morris Trust merger.
Key Events · M&A and Partnerships · THRM
-
Special Meeting Set for September 10
Shareholders of record as of July 31, 2026 will vote on the share issuance and charter amendment proposals required to complete the merger with Modine's Performance Technologies business.
-
Estimated Merger Consideration
Gentherm expects to issue approximately 20,846,994 shares valued at about $882.0 million based on the July 30, 2026 closing price of $42.32 per share.
-
Charter Amendment to Double Authorized Shares
The proposal would increase authorized common shares from 55 million to 110 million to accommodate the merger issuance.
-
Potential Special Dividend
If the exchange ratio is adjusted upward to preserve tax-free treatment, Gentherm may pay a special dividend ranging from $0.01 to $3.68 per share to pre-merger shareholders.
Analysis · THRM · Manufacturing
The proxy statement for the special shareholder meeting to approve the Reverse Morris Trust merger with Modine's Performance Technologies business has been mailed. Shareholders of record as of July 31, 2026 will vote on September 10, 2026 on the share issuance and charter amendment needed to complete the deal. The estimated merger consideration is 20.8 million Gentherm shares valued at approximately $882 million based on the July 30 closing price. The charter amendment would double authorized shares to 110 million. If the exchange ratio is adjusted upward to preserve tax-free treatment, Gentherm may pay a special dividend of up to $3.68 per share. The deal is expected to close in Q4 2026, subject to shareholder approval and other conditions.
At the time of this filing, THRM was trading at $41.41 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $27.00 to $48.35. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.